KQED Nightly Business Report April 22, 2015
Bid for mylan. The price tag 40 billion, the largest potential takeover in the drug industry this year. The shares of mylan soared 8 and the shares for teva were higher. This could change the landscape of the industry but there is no guarantee anything about it will be easy. Megan tirrell has more. Another day and another deal in the drug industry. Nevas offer for rival mylan comes on the heels of mylans offer to buy periggo, a move some expected to be defensive. It contributed to deal activity among drug companies. You have to be big or you will get acquired. But mylan is not expected to go e...